Regional Medicare Advantage HMO — URAC Medicare Advantage Organization Accreditation

Last updated: April 2026

Client identity withheld per IHS confidentiality policy. Operational details reflect actual engagement experience. All compliance findings and outcomes are documented from IHS project records.

Engagement Snapshot

• Organization type: Regional Medicare Advantage HMO with MA-PD product line
• Geography: Multi-county service area, southeastern United States
• Enrollment: Mid-size plan, below threshold for large-plan CMS audit targeting
• Accreditation sought: URAC Medicare Advantage Organization Accreditation (standard pathway)
• Engagement duration: Eleven months from initial gap analysis to accreditation award
• IHS lead: Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC

The Situation

The plan had operated under its CMS contract for several years and maintained a stable Star Ratings performance record. Leadership identified two strategic drivers for pursuing URAC Medicare Advantage Organization Accreditation:

1. Regulatory positioning. CMS Part C audit activity had increased across their region. The plan's compliance officer wanted a third-party validated framework across the five deemable domains before the next audit cycle — not as a guarantee of audit bypass, but as a documented foundation of operational rigor.
2. Market differentiation. The plan was negotiating with a regional employer group that had begun asking about accreditation status as part of its preferred MA plan evaluation criteria. Third-party accreditation was becoming a differentiator in broker and employer channels where the plan competed.

The plan had no prior URAC accreditation of any kind. Their compliance infrastructure had been built reactively around CMS audit requirements and Star Ratings measurement — functional, but not structured around a coherent quality governance framework.

What the Gap Analysis Found

IHS conducted a comprehensive gap analysis against URAC Medicare Advantage standards in the first six weeks of engagement. The assessment identified material gaps in three of the five deemable domains and partial gaps in the remaining two.

Quality Improvement — Material Gap

The plan had a Quality Improvement program in name and structure, but the committee governance was underdeveloped for URAC standards. Specifically:

• The QI committee charter did not define quorum, voting authority, or escalation pathways — required elements under URAC's program governance standards
• Performance Improvement Projects (PIPs) existed but lacked documented methodology, baseline establishment, intervention rationale, and formal re-measurement cycles
• Performance data was collected for Star Ratings reporting but was not being internally trended, analyzed, and reported to the QI committee in a URAC-compliant format
• The annual QI program evaluation had not been conducted within the prior twelve months

Advance Directives — Material Gap

This was the most operationally complex gap. CMS requires Medicare Advantage plans to inform enrollees of their rights regarding advance directives and to document that communication. URAC's standard adds specificity around when and how that communication must occur across the member lifecycle.

• The plan's advance directives notice was included in the enrollment welcome packet — but not consistently sent as a standalone communication or at required intervals thereafter
• No tracking mechanism existed to document which members had received the communication, when, and in what form
• Member services staff had no documented protocol for handling advance directives inquiries or requests

Provider Participation Rules — Material Gap

The plan maintained provider agreements and credentialing processes that met CMS network adequacy requirements, but the written criteria governing provider participation decisions were not codified in formal policy accessible to providers and internally auditable.

• Participation denial and termination criteria existed in practice but were not consistently documented in written form
• The plan had no formal written process for providers to appeal participation decisions — a specific URAC requirement
• Network adequacy monitoring was conducted but results were not formally reported to the QI committee

Anti-Discrimination — Partial Gap

The plan's nondiscrimination policies were generally sound, but member-facing communications had not been reviewed for consistency with the policy language, and training documentation for staff on anti-discrimination obligations was outdated.

Confidentiality and Accuracy of Enrollee Records — Partial Gap

HIPAA-required privacy controls were in place. The gap was in documentation specificity: the plan's privacy policies referenced HIPAA standards but did not explicitly describe the additional data governance controls URAC standards require, particularly around accuracy verification and member data correction processes.

The IHS Approach

With gaps identified across all five deemable domains, IHS prioritized the work in two phases — addressing the material gaps first because they required operational change, not just documentation revision.

Phase 1: Structural Rebuilds (Months 2–5)

Quality Improvement Program Overhaul

IHS rebuilt the QI program governance structure from the committee charter outward. The revised charter defined quorum requirements, voting authority, required attendance, minutes protocols, and escalation pathways for quality findings requiring executive action. Two Performance Improvement Projects were redesigned with URAC-compliant methodology: documented baseline, defined intervention, measurement intervals, and re-measurement cycles. A QI reporting calendar was established to ensure committee-ready performance data packages were produced quarterly.

Advance Directives Workflow Reconstruction

The advance directives communication gap required building a new workflow, not revising an existing one. IHS designed a multi-touchpoint communication protocol — initial enrollment, annual notice, and triggered notice upon hospitalization or care transition — with documentation requirements at each stage. A member-level tracking mechanism was implemented in the plan's enrollment system. Member services staff received a documented protocol for advance directives inquiries, with escalation criteria for complex situations.

Provider Participation Policy Architecture

IHS developed formal written criteria for provider participation decisions — both initial credentialing and ongoing participation — and a written appeal process accessible to providers. Network adequacy monitoring results were integrated into the QI committee reporting cycle, creating a documented governance connection between network performance and quality oversight.

Phase 2: Documentation Remediation (Months 5–7)

With structural gaps closed, IHS addressed the partial gaps in Anti-Discrimination and Confidentiality through policy revision, communication review, and training documentation updates. Member-facing communications were reviewed against the nondiscrimination policy language and revised for consistency. Staff training records were updated and a refresher training delivered and documented.

Mock Survey (Month 8)

IHS conducted a full mock survey against URAC Medicare Advantage standards before submission. The mock survey identified two remaining documentation issues:

• The QI annual evaluation document did not include a required forward-looking section identifying priorities for the coming year — corrected before submission
• The provider participation appeal process policy had not been formally adopted by the plan's governing body — a board resolution was obtained and documented

Submission and RFI Response (Months 9–11)

IHS prepared and managed the AccreditNet submission with complete supporting documentation. URAC issued a single RFI requesting additional detail on the QI performance trending methodology — specifically, how the plan determined statistical significance of performance changes before classifying them as improvements versus normal variation. IHS drafted the response with the specific methodological description URAC required, citing the plan's internal data analysis protocols. No further RFI was issued. The plan received its accreditation determination in month eleven.

Outcomes

Accreditation Achieved

URAC Medicare Advantage Organization Accreditation awarded — three-year term. All five deemable domains satisfied without conditions or corrective action requirements.

Regulatory Positioning

The plan entered its next CMS audit cycle with documented compliance frameworks across the five deemable domains, formal QI committee governance on record, and an advance directives communication system with member-level tracking. The compliance officer reported that internal audit preparation time for the deemable domains was materially reduced because the documentation infrastructure was already in place.

Market Differentiation

The employer group negotiation that had originally prompted the accreditation pursuit was successfully concluded. The plan's URAC accreditation was cited by the employer group's benefits consultant as a differentiating factor in the evaluation. The plan subsequently added accreditation status to its broker materials and RFP response templates.

Quality Improvement Infrastructure

The QI program rebuild produced a secondary benefit beyond accreditation: the plan's QI committee began identifying performance trends that had previously gone unanalyzed. One PIP focused on care transitions documentation — identified during the QI infrastructure rebuild — contributed to measurable improvement in a Star Ratings measure in the following measurement year.

Advance Directives Compliance

The new advance directives workflow eliminated the tracking gap that had existed prior to the engagement. The plan's compliance team now has member-level documentation of advance directives communications — evidence that would be directly relevant in any CMS audit of the advance directives domain.

Key Lessons from This Engagement

Paper compliance fails at the URAC review stage.

The plan had existing policies for most of the five deemable domains. What they lacked was operational embedding — the practices existed but weren't documented as systematic processes. URAC reviewers assess whether policies are operationalized, not just whether they exist in a policy manual. Organizations that create policies the week before submission will not pass review.

Quality Improvement governance is the load-bearing structure.

The QI domain is not a checkbox — it is the organizing framework that connects network performance, advance directives, anti-discrimination, and data governance into a coherent quality program. Plans that treat QI as a standalone reporting exercise will have to rebuild it for URAC. Plans that build genuine QI governance get accreditation and better Star Ratings infrastructure as joint outputs.

The RFI is not a failure — but the response determines whether it becomes one.

One RFI in this engagement, focused on statistical methodology in QI trending. A vague response would have triggered a second RFI or a deficiency finding. The precise response — describing the specific methodology in operational terms — resolved the finding in a single exchange. RFI response quality is the primary variable that separates efficient accreditation processes from prolonged ones.

Accreditation ROI compounds.

The plan pursued accreditation for regulatory positioning and market differentiation. The secondary benefit — genuine improvement in QI infrastructure and a measurable Star Ratings contribution — was not anticipated at engagement start. Organizations that build real compliance programs for URAC accreditation, rather than minimum viable documentation packages, consistently find that the investment pays returns beyond the accreditation credential itself.

Is Your Medicare Advantage Plan Ready for URAC Accreditation?

IHS can assess your plan's current compliance posture across the five deemable domains and give you an honest gap analysis before you commit to an accreditation timeline. Contact us for a direct conversation with Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC.

Engagements are scoped per client situation. There is no standard fee schedule.